Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Português | LILACS, SES-SP, SESSP-IALPROD, SES-SP, SESSP-IALACERVO | ID: biblio-1007421

RESUMO

Chagas disease is a neglected protozoan disease that affects more than eight million people in developing countries. Due to the limited number and toxicity profiles of therapies in current use, new drugs are urgently needed. In previous studies, we reported the isolation of two related antitrypanosomal neo- lignans from Nectandra leucantha (Lauraceae). In this work, a semi-synthetic library of twenty-three neolignan derivatives was prepared to explore synthetically accessible structure activity relationships (SAR) against Trypanosoma cruzi. Five compounds demonstrated activity against trypomastigotes (IC50 values from 8 to 64 mM) and eight showed activity against intracellular amastigotes (IC50 values from 7 to 16 mM). Eighteen derivatives demonstrated no mammalian cytotoxicity up to 200 mM. The phenolic ac- etate derivative of natural dehydrodieugenol


Assuntos
Trypanosoma cruzi , Doença , Doença de Chagas
2.
Rev. bras. farmacogn ; 21(1)jan.-fev. 2011. tab
Artigo em Inglês | LILACS | ID: lil-580329

RESUMO

The essential oil of the leaves from Annona coriacea Mart., Annonaceae, was extracted by hydrodistillation in a Clevenger apparatus and analyzed by GC/MS and GC/FID. The oil yield was 0.05 percent m/m. Sixty compounds were identified, in a complex mixture of sesquiterpenes (76.7 percent), monoterpenes (20.0 percent) and other constituents (3.3 percent). Bicyclogermacrene was its major compound (39.8 percent) followed by other sesquiterpenes. Most of the monoterpenes were in low concentration (<1 percent). Only β-pinene and pseudolimonene presented the highest level of 1.6 percent. The volatile oil presented anti-leishmanial and trypanocidal activity against promastigotes of four species of Leishmania and trypomastigotes of Trypanosoma cruzi, showing to be more active against Leishmania (L.) chagasi (IC50 39.93 µ g/mL) (95 percent CI 28.00-56.95 µ g/mL).

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA